Our goal is to serve as a resource for all Canadians affected by aHUS, and form a nationwide community of aHUS patients.
PR Newswire UK – September 12, 2013
NHS England Commissions Soliris® for the Treatment of Atypical Haemolytic Uraemic Syndrome (aHUS)
Stay connected with the aHUS community in Canada! To receive info and updates from aHUS Canada, sign up here:
In addition to providing support to patients and caregivers, aHUS Canada strives to connect those affected by the condition to establish a Canadian aHUS community, build public awareness and understanding of this very rare and potentially fatal disease and advocate for the best possible care and treatment for patients.